Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 18 analysts that cover Apellis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $33.11, which forecasts a 40.12% increase in the stock price over the next year. The lowest target is $18 and the highest is $52.

Price Target: $33.11 (+40.12%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$33.11	$32	$52
Change	-23.83%	+40.12%	+35.42%	+120.06%

* Price targets were last updated on Nov 5, 2025.

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	3	3	4	4	4
Buy	6	7	7	7	7	6
Hold	9	10	9	8	9	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	1	1	1	1
Total	19	20	20	20	21	19

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andy Chen Wolfe Research	Wolfe Research	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Nov 6, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $40 → $36	Buy	Maintains	$40 → $36	+52.35%	Nov 5, 2025
Graig Suvannavejh Mizuho	Mizuho	Hold Maintains $24 → $19	Hold	Maintains	$24 → $19	-19.59%	Nov 3, 2025
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $52 → $45	Strong Buy	Maintains	$52 → $45	+90.44%	Oct 31, 2025
Phil Nadeau TD Cowen	TD Cowen	Strong Buy Maintains $50 → $45	Strong Buy	Maintains	$50 → $45	+90.44%	Oct 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.01B

Increased by 29.00%

from 781.37M

Revenue Next Year

884.42M

Decreased by -12.26%

from 1.01B

EPS This Year

0.27

from -1.60

EPS Next Year

-1.12

from 0.27

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	250.65M	66.56M	75.42M	396.59M	781.37M	1.01B	884.42M
Revenue Growth	-	-73.44%	13.31%	425.83%	97.02%	29.00%	-12.26%
EPS	-4.59	-8.84	-6.15	-4.45	-1.60	0.27	-1.12
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	89.10	-
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.0B
Avg	1.0B	884.4M
Low	684.3M	771.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	41.2%	-0.5%
Avg	29.0%	-12.3%
Low	-12.4%	-23.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.50	0.44
Avg	0.27	-1.12
Low	0.13	-1.70

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	67.1%
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.